An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats

BMC Musculoskeletal Disorders

Miho Sekiguchi¹  Shin-ichi Konno¹  Shin-ichi Kikuchi¹  Bunji Takayama¹ 

[1] Department of Orthopedic Surgery, Fukushima Medical University School of Medicine, 1-Hikarigaoka, Fukushima City, Fukushima, 960-1295, Japan

Others  :  1159463
DOI  :  10.1186/1471-2474-9-164

 received in 2008-06-27, accepted in 2008-12-15,  发布年份 2008

【 摘 要 】

Background

Calcitonin is used as a treatment to reduce the blood calcium concentration in hypercalcemia and to improve bone mass in osteoporosis. An analgesic effect of calcitonin has been observed and reported in clinical situations. Ovariectomaized (OVX) rats exhibit the same hormonal changes as observed in humans with osteoporosis and are an animal model of postmenopousal osteoporosis. The aim of this study to investigate antinociceptive effect of calcitonin in OVX rats using the immunohistochemical study.

Methods

We assessed the antinociceptive effects of calcitonin in an ovariectomized (OVX) rat model, which exhibit osteoporosis and hyperalgesia, using the immunohistochemical method. Fifteen rats were ovariectomized bilaterally, and ten rats were received the same surgery expected for ovariectomy as a sham model. We used five groups: the OVX-CT (n = 5), the sham-CT (n = 5), and the OVX-CT-pcpa (n = 5) groups recieved calcitonin (CT: 4 U/kg/day), while OVX-vehi (n = 5) and the sham-vehi (n = 5) groups received vehicle subcutaneously 5 times a week for 4 weeks. The OVX-CT-pcpa-group was given traperitoneal injection of p-chlorophenylalanine (pcpa; an inhibitor of serotonin biosynthesis) (100 mg/kg/day) in the last 3 days of calcitonon injection. Two hours after 5% formalin (0.05 ml) subcutaneously into the hind paw, the L5 spinal cord were removed and the number of Fos-immunoreactive (ir) neurons were evaluated using the Mann-Whitney-U test.

Results

The numbers of Fos-ir neurons in the OVX-CT and sham-CT groups were significantly less than in the OVX-vehi and sham-vehi groups, respectively (p = 0.0090, p = 0.0090). The number of Fos-ir neurons in the OVX-CT-pcpa-group was significantly more than that of the OVX-CT-group (p = 0.0283), which means pcpa inhibits calcitonin induced reduction of c-Fos production.

Conclusion

The results in this study demonstrated that 1) the increase of c-Fos might be related to hyperalgesia in OVX-rats. 2) Calcitonin has an antinociceptive effect in both OVX and sham rats. 3) The central serotonergic system is involved in the antinociceptive properties of calcitonin.

【 授权许可】

   
2008 Takayama et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Knopp JA, Diner BM, Blitz M, et al.: Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 2005, 16:1281-1290.
• [2]Lyritis GP, Ioannidis GV, Karachalios T, et al.: Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 1999, 15:284-289.
• [3]Gobelet C, Waldburger M, Meier JL: The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain 1992, 48:171-175.
• [4]Roth A, Kolaric K: Analgetic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. Results of a controlled randomized study. Oncology 1986, 43:283-287.
• [5]Albright F: Annals of internal medicine, volume 27,1947 Osteoporosis. Nutr Rev 1989, 47(3):85-86.
• [6]Beato M: Gene regulation by steroid hormones. Cell 1989, 56:335-344.
• [7]Wronski TJ, Lowry PL, Walsh CC, et al.: Skeletal alternations in ovariectomized rats. Calcif Tissue Int 1985, 37:324-328.
• [8]Foreman LJ, Tingle V, Estilow S, et al.: The response to analgesia testing is affected by gonadal steroids in the rat. Life Sci 1989, 45:447-454.
• [9]Franceschini R, Bottaro P, Panopoulos C, et al.: Long-term treatement with salmon calcitonin in postmenopausal osteoporosis. Curr Ther Res 1983, 34:795-800.
• [10]Hunt SP, Pini A, Evan G: Induction of c-fos like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328:632-634.
• [11]Menetrey D, Gannon A, Levine JD, et al.: Expression of c-fos protein in interneurons and projection neurons of the spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol 1989, 285:177-195.
• [12]Morgan JI, Curran T: Stimulus transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun. Trends Neurosci 1989, 12:459-462.
• [13]Naranjo JR, Mellstörm B, Achaval M, et al.: Molecular pathways of pain: Fos/Jun- mediated activation of a noncanonical AP-1 site in the predynorphim gene. Neuron 1991, 6:607-617.
• [14]Sonnenberg JL, Rauscher FJ, Morgan JI, et al.: Reguration of proenkephalin by Fos and Jun. Sciensce 1989, 246:1622-1625.
• [15]Buritova J, Honore P, Besson JM: Ketoprofen produces profound inhibition of spinal c-fos protein expression resulting from an inflammatory stimulus but not from noxious heart. Pain 1996, 67:379-389.
• [16]Carrive P, Meyer-Carrive I: Changes in formalin-evoked spinal Fos expression and nociceptive behavior after oral administration of bufferin A(aspirin) and L-5409709(ibuprofen+caffeine+paracetamol). Pain 1997, 70:253-266.
• [17]Lima D, Avelino A, Coimbra A: Differential activation of c-fos in spinal neurons by distinct classes of noxious stimuli. Neuroreport 1993, 4:747-750.
• [18]Presley RW, Menetrey D, Levine JD, et al.: Systemic morphine suppresses noxious stimulus evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 1990, 10:323-335.
• [19]Hamba M, Muro M, Hiraide T, et al.: Expression of c-fos like protein of in the rat brain after injection of interleukin-1-beta into the gingiva. Brain Res Bull 1994, 34:61-68.
• [20]Shibata K, Takeda M, Ito A, et al.: Ovariectomy-induced hyperalgesia and antinociceptive effect of elcatonin, a synthetic eel calcitonin. Pharmacol Biochem Behav 1998, 60:371-376.
• [21]Molander C, Xu Q, Grant G: The cytoarchitectonic organization of the spinal cord in the rat : the lower thoratic and lumbosacral cord. J Comp Neurol 1984, 230:133-141.
• [22]Dickenson AH, Sullivan AF: Subcutaneous formalin-induced activity of doreal horn neurons in the rat; differential response to an intrathecal opiate administered pre or post formalin. Pain 1987, 30:349-60.
• [23]Dubuisson D, Dennis SG: The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stimulation in rats and cats. Pain 1977, 4:161-174.
• [24]Tokunaga A, Doi M, Senba E: Effects of local anaesthesia on formalin-induced Fos expression in the rat dorsal horn. Neuroreport 1995, 6(17):2301-2304.
• [25]Ilaria C, Paolo F, Cosimo M, et al.: Long term ovareiectomy changes formalin induced licking in female rats: the role of estrogens. Reproductive Biology and Endocrinology 2003, 1:24. BioMed Central Full Text
• [26]Sanchez R, Nguyen D, Rocha W, et al.: Diversity in the mechanisms of gene regulation by estrogen receptors. Bioassays 2002, 24:244-254.
• [27]Ito A, Kumamoto E, Takeda M, et al.: Mechanisms for Ovariectomy-induced hyperalgesia and its relief by calcitonin: Participation of 5 HT1A-like receptor on C-afferent terminals in Substantia Geratinoza of the Rat spinal cord. J Neurosci 2000, 20:6302-6308.
• [28]Kuraishi Y, Minami M, Satoh M, et al.: Serotonin, but neither noradrenaline nor GABA, inhibits capsaicin-evoked release of immunoreactive somatostatin from slices of rat spinal cord. Neurosci Res 1991, 9:238-245.
• [29]Clementi G, Amico-Roxas M, Rapisarda E, et al.: The analgesic activity of calcitonin and the central sertonergic system. Eur J Pharmacol 1985, 108:71-75.
• [30]Fabbri A, Frarioli F, Pert CB, et al.: Calcitonin receptors in rat mesencephalon medidate its analgesic actions: Autoradiographic and behavioral analyses. Brain Res 1985, 343:205-215.
• [31]Guidobono F, Netti C, Pagani F, et al.: Relationship between analgesia induced by centrally injected calcitonin to the CNS serotonergic system. Neuropeptides 1986, 8:259-271.
• [32]Spampinato S, Candeletti S, Cavicchini E, et al.: Antinociceptive activity of salmon calcitonin injected intrathecally in the rat. Neurosci Lett 1984, 45:135-139.
• [33]Guidobono F, Netti C, Pagani F, et al.: Evidence for different classes of calcitonin binding sites in rat CNS: An autoradiographic study with carbo-calcitonin. Neurosci Lett 1987, 79:91-96.
• [34]Rizzo AJ, Golzman D: Calcitonin receptors in central nervous system of the rat. Endocrinol Invest 1991, 14:47-51.
• [35]Gennari C, Agnusdei D: Calcitonin in bone pain management. Curr Ther Res 1998, 44:712-722.
• [36]Elliott K, Brodsky M, Hynansky AD, et al.: Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995, 61:401-409.
• [37]Sun WZ, Shyu BC, Shieh JY: Nitrous oxide or halothane, or both, fail to suppress c-fos expression in rat spinal cord dorsal horn neurones after subcutaneous formalin. British J Anaesthesia 1996, 76:99-105.
• [38]Sekiguchi M, Shirasaka M, Konno S, et al.: Analgesic effect of percutaneously absorbed non-streroidal anti-inflammatory drugs: an experimental study in a rat acute inflammation model. BMC Musculoskelet Disord 9:15. BioMed Central Full Text
• [39]Sun X, Yokoyama M, MIzobuchi S, et al.: The effetcts of pretreatment with lidocaine or bupivacaine on the spatial and temporal expression of c-Fos protein in the spinal cord caused by plantar incision in the rat. Anesth Analg 2004, 98:1093-1098.
• [40]Silverman SL, Azria M: The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int 2002, 13:858-67.
• [41]Karsdal MA, Henriksen K, Arnold M, et al.: Calcitonin – A drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improve bone quality. BioDrugs 2008, 22(3):137-144.
• [42]Tanko LB, Sondergaard BC, Oestergaard S, et al.: An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric 2008, 11:4-16.
• [43]Oesterggard S, Sondergaard BC, Hoegh-Andersen P, et al.: Effects of ovariectomy and estrogen therapu on type II collagen degradation and structural integrity of articular cartilage in rats. Arthritis Rheum 2006, 54:2441-51.
• [44]Sondergaard BC, Oestergaard S, Christiansen C, et al.: The effects of oral calcitonin on cartilage turnover and surface erosion in an ovariectomaized rat model. Arthritis Rheum 2007, 56:2674-8.
• [45]Umeno H, Nagasawa T, Yamazaki N, et al.: Antinociceptive effects of repeated systemic injections of calcitonin in formalin -induced hyperalgesic rats. Pharmacol Biochem Behav 1996, 55:151-156.